Medivie Therapeutic Ltd
Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the c… Read more
Medivie Therapeutic Ltd (MDVI) - Total Liabilities
Latest total liabilities as of June 2021: ILA9.13 Million ILA
Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) has total liabilities worth ILA9.13 Million ILA as of June 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medivie Therapeutic Ltd - Total Liabilities Trend (2010–2020)
This chart illustrates how Medivie Therapeutic Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medivie Therapeutic Ltd Competitors by Total Liabilities
The table below lists competitors of Medivie Therapeutic Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MANCHESTER UTD A
MU:MUF
|
Germany | €1.20 Billion |
|
R STAHL N
BE:RSL2
|
Germany | €204.47 Million |
|
PREOS Global Office Real Estate & Technology AG
MU:PAG
|
Germany | €286.81 Million |
Liability Composition Analysis (2010–2020)
This chart breaks down Medivie Therapeutic Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.95 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medivie Therapeutic Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medivie Therapeutic Ltd (2010–2020)
The table below shows the annual total liabilities of Medivie Therapeutic Ltd from 2010 to 2020.
| Year | Total Liabilities | Change |
|---|---|---|
| 2020-12-31 | ILA8.46 Million | +11.21% |
| 2019-12-31 | ILA7.61 Million | +76.26% |
| 2018-12-31 | ILA4.32 Million | +25.23% |
| 2017-12-31 | ILA3.45 Million | +91.02% |
| 2016-12-31 | ILA1.80 Million | +63.35% |
| 2015-12-31 | ILA1.10 Million | -35.90% |
| 2014-12-31 | ILA1.72 Million | -15.90% |
| 2013-12-31 | ILA2.05 Million | +40.70% |
| 2012-12-31 | ILA1.46 Million | -84.60% |
| 2011-12-31 | ILA9.46 Million | -0.89% |
| 2010-12-31 | ILA9.55 Million | -- |